United Therapeutics Corporation reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 794.4 million compared to USD 677.7 million a year ago. Net income was USD 322.2 million compared to USD 306.6 million a year ago.

Basic earnings per share from continuing operations was USD 7.18 compared to USD 6.52 a year ago. Diluted earnings per share from continuing operations was USD 6.63 compared to USD 6.17 a year ago.